0001144204-17-010282.txt : 20170222 0001144204-17-010282.hdr.sgml : 20170222 20170222060353 ACCESSION NUMBER: 0001144204-17-010282 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170222 DATE AS OF CHANGE: 20170222 GROUP MEMBERS: DR. ANAND MEHRA GROUP MEMBERS: DR. JAMES I. HEALY GROUP MEMBERS: DR. MICHAEL F. POWELL GROUP MEMBERS: SOFINNOVA MANAGEMENT VIII, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Innocoll Holdings plc CENTRAL INDEX KEY: 0001660484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-89451 FILM NUMBER: 17626980 BUSINESS ADDRESS: STREET 1: UNIT 9, BLOCK D, MONKSLAND BUSINESS PARK STREET 2: MONKSLAND CITY: ATHLONE STATE: L2 ZIP: NONE BUSINESS PHONE: 353(0) 90 6486834 MAIL ADDRESS: STREET 1: UNIT 9, BLOCK D, MONKSLAND BUSINESS PARK STREET 2: MONKSLAND CITY: ATHLONE STATE: L2 ZIP: NONE FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova Venture Partners VIII, L.P. CENTRAL INDEX KEY: 0001524064 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-681-8420 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13D/A 1 v460109_sc13da.htm SC 13D/A

 

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

SCHEDULE 13D

(RULE 13d-101)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)

AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

 

(Amendment No. 1)*

 

Innocoll Holdings Public Limited Company

(Name of Issuer)

 

Ordinary Shares, $.01 par value per share

(Title of Class of Securities)

 

G4783X105

 

(CUSIP Number)

 

Nathalie Auber

Sofinnova Ventures, Inc.

3000 Sand Hill Road, Bldg. 4, Suite 250

Menlo Park, CA 94025

(650) 681-8420

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

COPY TO:

Linda Daley, Esq.

c/o Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP

1200 Seaport Blvd., Redwood City, CA  94063

(650) 463-5243

 

June 17, 2016

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

This information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Sofinnova Venture Partners VIII, L.P. (“SVP VIII”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                                                                                                   (a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

2,103,173 Ordinary Shares except that Sofinnova Management VIII, L.L.C. (“SM VIII”), the general partner of SVP VIII, may be deemed to have sole voting power, and Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”) and Dr. Anand Mehra (“Mehra”), the managing members of SM VIII, may be deemed to have shared power to vote these Ordinary Shares.

8

SHARED VOTING POWER

See response to row 7.

9

SOLE DISPOSITIVE POWER

2,103,173 Ordinary Shares except that SM VIII, the general partner of SVP VIII, may be deemed to have sole dispositive power and Powell, Healy and Mehra, the managing members of SM VIII, may be deemed to have shared power to dispose of these Ordinary Shares.

10

SHARED DISPOSITIVE POWER

See response to row 9.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,103,173
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11    7.1%
14 TYPE OF REPORTING PERSON  PN

 

 

 

 

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Sofinnova Management VIII, L.L.C. (“SM VIII”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                                                                                                   (a)     ¨     (b)     x

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF 

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

2,103,173 Ordinary Shares, all of which are owned directly by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole voting power, and Powell, Healy and Mehra, the managing members of SM VIII, may be deemed to have shared power to vote these Ordinary Shares.

8

SHARED VOTING POWER

See response to row 7.

9

SOLE DISPOSITIVE POWER

2,103,173 Ordinary Shares, all of which are owned directly by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole dispositive power, and Powell, Healy and Mehra, the managing members of SM VIII, may be deemed to have shared dispositive power over these Ordinary Shares.

10

SHARED DISPOSITIVE POWER

See response to row 9.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,103,173
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11    7.1%
14 TYPE OF REPORTING PERSON  OO

 

 

 

 

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Dr. Michael F. Powell (“Powell”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                                                                                                   (a)     ¨     (b)     x

3

SEC USE ONLY

4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION     U.S. Citizen

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole voting power, and Powell, a managing member of SM VIII, may be deemed to have shared voting power to vote these Ordinary Shares.

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole dispositive power, and Powell, a managing member of SM VIII, may be deemed to have shared power to dispose of these Ordinary Shares.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,103,173
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11    7.1%
14 TYPE OF REPORTING PERSON  IN

 

 

 

 

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Dr. James I. Healy (“Healy”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                                                                                                   (a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION     U.S. Citizen

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole voting power, and Healy, a managing member of SM VIII, may be deemed to have shared voting power to vote these Ordinary Shares.

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole dispositive power, and Healy, a managing member of SM VIII, may be deemed to have shared power to dispose of these Ordinary Shares.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,103,173
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11    7.1%
14 TYPE OF REPORTING PERSON  IN

 

 

 

 

1

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Dr. Anand Mehra (“Mehra”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                                                                                                   (a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

U.S. Citizen 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING

PERSON

WITH

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole voting power, and Mehra, a managing member of SM VIII, may be deemed to have shared voting power to vote these Ordinary Shares.

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

2,103,173 Ordinary Shares, all of which are directly owned by SVP VIII. SM VIII, the general partner of SVP VIII, may be deemed to have sole dispositive power, and Mehra, a managing member of SM VIII, may be deemed to have shared power to dispose of these Ordinary Shares.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,103,173
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11    7.1%
14 TYPE OF REPORTING PERSON  IN

 

 

 

 

Amendment No. 1 to Statement on Schedule 13D

 

This Amendment No. 1 (“Amendment No. 1”) amends and restates the statement on Schedule 13D initially filed on August 4, 2014 (the “Original Schedule 13D”) relating to the beneficial ownership of American Depositary Shares (“ADSs”), each representing 1/13.25 of an Ordinary Share, €1.00 nominal value per share of Innocoll AG (the “Predecessor Issuer”), filed by and on behalf of Sofinnova Venture Partners VIII, L.P., a Delaware limited partnership (“SVP VIII”), Sofinnova Management VIII, L.L.C., a Delaware limited liability company (“SM VIII”), Dr. Srinivas Akkaraju (“Akkaraju”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”) and Dr. Anand Mehra (“Mehra”). Akkaraju is no longer a managing member of SM VIII, and “Reporting Persons” for this Amendment No. 1 shall mean SVP VIII, SM VIII, Powell, Healy and Mehra, collectively. On March 16, 2016, the Predecessor Issuer merged with Innocoll Holdings plc (the “Issuer”) by way of a European cross-border merger with the Issuer being the surviving company (the “Merger”). Upon the effectiveness of the Merger, the Predecessor Issuer ADS facility was terminated and each cancelled ADS effectively became an entitlement to receive one Ordinary Share of Issuer, and accordingly this Amendment No. 1 relates to the Ordinary Shares of Issuer, $.01 par value per share.

 

Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. This Amendment No. 1 is being filed to reflect the purchase of additional Predecessor Issuer American Depositary Shares in the April 2015 secondary public offering by the Predecessor Issuer, the purchase of additional Ordinary Shares of Issuer in the June 2016 secondary public offering by the Issuer, and the decrease of the Reporting Persons’ percentage beneficial ownership of the Issuer.

 

ITEM 1.SECURITY AND ISSUER.

 

(a)          The class of equity securities to which this statement relates is the Ordinary Shares of Issuer.

 

(b)          The Issuer’s principal executive offices are located at Unit 9, Block D, Monksland Business Park, Monksland, Athlone, Ireland.

 

ITEM 2.IDENTITY AND BACKGROUND.

 

(a)          The persons and entities filing this Schedule 13D are SVP VIII, SM VIII, Powell, Healy, and Mehra. SM VIII, the general partner of SVP VIII, may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer directly owned by SVP VIII.

 

(b)          The address of the principal place of business for each of the Reporting Persons is c/o Sofinnova Ventures, 3000 Sand Hill Road, Bldg 4, Suite 250 Menlo Park, California 94025.

 

(c)          The principal occupation of each of the Reporting Persons is the venture capital investment business. The principal business of SVP VIII is to make investments in private and public companies, and the principal business of SM VIII is to serve as the general partner of SVP VIII. Powell, Healy and Mehra are the managing members of SM VIII.

 

(d)          During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).

 

(e)          During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

(f)          SVP VIII is a Delaware limited partnership. SM VIII is a Delaware limited liability company. Powell, Healy, and Mehra are U.S. citizens.

 

 

 

 

ITEM 3.SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

 

On July 30, 2013 SVP VIII purchased 1,666,666 ADSs at the initial public offering of the Predecessor Issuer at the initial public offering price of $9.00 per ADS, for an aggregate purchase price of $15,000,000. Such ADSs converted into 1,666,666 Ordinary Shares of the Issuer in the Merger. The source of the funds for the purchase was from working capital.

 

On April 24, 2015 SVP VIII purchased 222,222 ADSs of the Predecessor Issuer in a secondary public offering by the Predecessor Issuer at $9.00 per ADS, or $ 1,999,998 in the aggregate. Such ADSs converted into 222,222 Ordinary Shares of the Issuer in the Merger. The source of the funds for the purchase was from working capital.

 

On June 17, 2016 SVP VIII purchased 214,285 Ordinary Shares of the Issuer in a secondary public offering by the Issuer at the public offering price of $7.00 per share, or $1,499,995 in the aggregate. The source of funds for the purchase was from working capital.

 

No part of the purchase price was borrowed by any Reporting Person for the purpose of acquiring any securities discussed in this Item 3.

 

ITEM 4.PURPOSE OF TRANSACTION.

 

SVP VIII holds its securities of the Issuer for investment purposes. Depending on the factors discussed herein, the Reporting Persons may, from time to time, acquire Ordinary Shares and/or retain and/or sell all or a portion of the Ordinary Shares held by the Reporting Persons in the open market or in privately negotiated transactions, and/or may distribute the Ordinary Shares held by the Reporting Persons to their respective members or limited partners. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons’ review of numerous factors, including, among other things, the price levels of the Ordinary Shares, general market and economic conditions, ongoing evaluation of the Issuer's business, financial condition, operations and prospects; the relative attractiveness of alternative business and investment opportunities, and other future developments. Except as set forth above, the Reporting Persons have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

 

ITEM 5.INTEREST IN SECURITIES OF THE ISSUER.

 

(a,b)         Regarding aggregate beneficial ownership, see Row 11 of the cover page of each Reporting Person. Regarding percentage beneficial ownership, see Row 13 of the cover page of each Reporting Person. Regarding sole power to vote shares, see Row 7 of the cover page of each Reporting Person. Regarding shared power to vote shares, see Row 8 of the cover page of each Reporting Person. Regarding sole power to dispose of shares, see Row 9 of the cover page of each Reporting Person. Regarding shared power to dispose of shares, see Row 10 of the cover page of each Reporting Person. The percentage listed in Row 13 for each Reporting Person was calculated based upon 29,731,551 Ordinary Shares outstanding on September 30, 2016 as reported by Issuer in its Form 6-K filed on November 22, 2016.

 

(c)          The Reporting Persons have not effected any transaction in the securities of the Issuer during the past 60 days.

 

(d)          Under certain circumstances set forth in the limited partnership agreement of SVP VIII, the general partner and limited partners of SVP VIII may be deemed to have the right to receive dividends from, or the proceeds from, the sale of Ordinary Shares of the Issuer owned by such entity of which they are a partner.

 

(e)          Not applicable.

 

ITEM 6.CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

 

In connection with the purchase of ADSs of Predecessor by SVP VIII in July 2013, certain of the Reporting Persons and certain other investors entered into a voting agreement regarding the election of a representative of SVP III to the Supervisory Board of Issuer. Such voting agreement automatically terminates upon the election of the SVP VIII representative to the Supervisory Board of Issuer. Such voting agreement is attached as Exhibit B hereto and is more fully described in the Prospectus and such description is incorporated herein by reference. The foregoing voting agreement terminated in accordance with its terms in December 2014. SVP VIII no longer has a representative to the Supervisory Board of Issuer.

 

 

 

  

ITEM 7.MATERIAL TO BE FILED AS EXHIBITS.

 

EXHIBIT A

Agreement of Joint Filing by and among Reporting Persons is incorporated herein by reference to Exhibit A of the Original Schedule 13D.
   
EXHIBIT B Form of Supervisory Board Member Nomination Agreement among Innocoll AG, Sofinnova Venture Partners VIII, L.P. and certain existing shareholders of Innocoll AG is incorporated herein by reference to Exhibit A to Exhibit 10.7 to the Issuer’s Registration Statement on Form F-1 filed with the SEC on July 24, 2014

 

 

 

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date:  February 21, 2017

 

  SOFINNOVA VENTURE PARTNERS VIII, L.P., a Delaware Limited Partnership
   
  By: SOFINNOVA MANAGEMENT VIII, L.L.C., a
  Delaware Limited Liability Company
  Its: General Partner

 

  By: /s/ Nathalie Auber
    Nathalie Auber
    Attorney-in-Fact

 

  SOFINNOVA MANAGEMENT VIII, L.L.C., a Delaware Limited Liability Company

 

  By: /s/ Nathalie Auber
    Nathalie Auber
    Attorney-in-Fact

 

  DR. JAMES I. HEALY
  DR. MICHAEL F. POWELL
  DR. ANAND MEHRA

 

  By: /s/ Nathalie Auber
    Nathalie Auber
    Attorney-in-Fact

 

*Signed pursuant to a Power of Attorney already on file with the appropriate agencies.